Progress of international hydrogen production network for the thermochemical Cu–Cl cycle

This paper presents recent advances by an international team which is developing the thermochemical copper–chlorine (Cu–Cl) cycle for hydrogen production. Development of the Cu–Cl cycle has been pursued by several countries within the framework of the Generation IV International Forum (GIF) for hydrogen production with the next generation of nuclear reactors. Due to its lower temperature requirements in comparison with other thermochemical cycles, the Cu–Cl cycle is particularly well matched with Canada's Generation IV reactor, SCWR (Super-Critical Water Reactor), as well as other heat sources such as solar energy or industrial waste heat. In this paper, recent developments of the Cu–Cl cycle are presented, specifically involving unit operation experiments, corrosion resistant materials and system integration

Extrusion foaming of plastic/wood-fiber composites using a chemical blowing agent

grantor: University of TorontoThis Thesis presents a study on feasibility of continuous extrusion processing for the manufacture of fine-celled plastic/wood-fiber composite foams. The main benefits of incorporating wood-fibers in plastics are the increased stiffness and lowered cost of the resulting composites. However, these improvements are usually accompanied by loss in the ductility and impact resistance of the composites. These shortcomings can be removed by effectively foaming and incorporating a fine-cell structure in the composites. Moisture removal is an important requirement for improving the foam structure. Various schemes of online moisture removal were explored and a promising process for the production of fine-celled plastic/wood-fiber composites foams has been developed. HDPE/wood-fiber composite foams, with significantly improved cell structure and a high volume expansion ratio up to nine-fold, have been successfully produced. For less stringent requirements, the feasibility of using the water, inherently present in the wood-fiber, as a blowing agent was also explored. The addition of a nucleating agent significantly improved the cell structure of PS/wood-fiber composite foams.M.A.Sc

Foaming of PS/wood fiber composites using moisture as a blowing agent

This paper presents an experimental study on foam processing of polystyrene (PS) and high-impact polystyrene HIPS/wood-fiber composites in extrusion using moisture as a blowing agent. Wood-fiber inherently contains moisture that can potentially be used as a blowing agent. Undried wood-fiber was processed together with PS and HIPS materials in extrusion and wood-fiber composite foams were produced. The cellular morphology and volume expansion ratios of the foamed composites were characterized. Because of the high stiffness of styrenic materials, moisture condensation during cooling after expansion at high temperature did not cause much contraction of the foamed composite and a high volume expansion ratio up to 20 was successfully obtained. The experimental results showed that the expansion ratio could be controlled by varying the processing temperature and the moisture content in the wood fiber. The effects of a small amount of a chemical blowing agent and mineral oil on the cell morphologies of plastic/wood-fiber composite foams were also investigated

Towards Analysis and Optimization of Electrospun PVP (Polyvinylpyrrolidone) Nanofibers

In this study, the polymeric nanofibers of polyvinylpyrrolidone (PVP) were manufactured using the electrospinning technique. The electrospinning process parameters such as voltage, polymer concentration, rotational speed of the collecting drum, collecting distance, and flow rate were optimized to obtain the minimum fiber diameter for sound absorption applications. The effects of these parameters on the fiber diameter as output responses were investigated by analysis of variance (ANOVA) and Taguchi’s array design. Furthermore, a mathematical model was generated using response surface methodology (RSM) to model the electrospinning process. The high voltage and polymer concentration were observed to be the most significant parameters at 95% and 99% confidence level. The average model accuracy of 83.4% was observed for the predictive model of electrospinning which is considered acceptable as it is composed of complete experimental trials of 27 out of 243 runs. The experimental study offers a promising attempt in the open literature to carefully understand the effect of various electrospinning parameters when producing PVP nanofibers

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson\u27s disease (PD MED): A large, open-label, pragmatic randomised trial

\ua9 2014 Elsevier Ltd. Background Whether initial treatment for Parkinson\u27s disease should consist of levodopa, dopamine agonists, or monoamine oxidase type B inhibitors (MAOBI) is uncertain. We aimed to establish which of these three classes of drug, as initial treatment, provides the most effective long-term control of symptoms and best quality of life for people with early Parkinson\u27s disease. Methods In this pragmatic, open-label randomised trial, patients newly diagnosed with Parkinson\u27s disease were randomly assigned (by telephone call to a central office; 1:1:1) between levodopa-sparing therapy (dopamine agonists or MAOBI) and levodopa alone. Patients and investigators were not masked to group assignment. Primary outcomes were the mobility dimension on the 39-item patient-rated Parkinson\u27s disease questionnaire (PDQ-39) quality-of-life scale (range 0-100 with six points defined as the minimally important difference) and cost-effectiveness. Analysis was intention to treat. This trial is registered, number ISRCTN69812316. Findings Between Nov 9, 2000, and Dec 22, 2009, 1620 patients were assigned to study groups (528 to levodopa, 632 to dopamine agonist, 460 to MAOBI). With 3-year median follow-up, PDQ-39 mobility scores averaged 1\ub78 points (95% CI 0\ub75-3\ub70, p=0\ub7005) better in patients randomly assigned to levodopa than those assigned to levodopa-sparing therapy, with no increase or attrition of benefit during 7 years\u27 observation. PDQ-39 mobility scores were 1\ub74 points (95% CI 0\ub70-2\ub79, p=0\ub705) better in patients allocated MAOBI than in those allocated dopamine agonists. EQ-5D utility scores averaged 0\ub703 (95% CI 0\ub701-0\ub705; p=0\ub70002) better with levodopa than with levodopa-sparing therapy; rates of dementia (hazard ratio [HR] 0\ub781, 95% CI 0\ub761-1\ub708, p=0\ub714), admissions to institutions (0\ub786, 0\ub763-1\ub718; p=0\ub74), and death (0\ub785, 0\ub769-1\ub706, p=0\ub717) were not significantly different, but the upper CIs precluded any substantial increase with levodopa compared with levodopa-sparing therapy. 179 (28%) of 632 patients allocated dopamine agonists and 104 (23%) of 460 patients allocated MAOBI discontinued allocated treatment because of side-effects compared with 11 (2%) of 528 patients allocated levodopa (p<0\ub70001). Interpretation Very small but persistent benefits are shown for patient-rated mobility scores when treatment is initiated with levodopa compared with levodopa-sparing therapy. MAOBI as initial levodopa-sparing therapy was at least as effective as dopamine agonists. Funding UK National Institute for Health Research Health Technology Assessment Programme and UK Department of Health